Cancer Therapy

Edited by : Neeraja Sankaran C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995) Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash. This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional st


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by : Neeraja Sankaran
C. Fleming, J.H. Wasson, P. Albertsen, M.J. Barry, J. E. Wennberg, "A decision analysis of alternative treatment strategies for clinically localized prostate cancer," Journal of the American Medical Association, 269:2650-8, 1993. (Cited in 88 publications through January 1995)

Comments by Craig Fleming, HealthOutcomes Associates, Vancouver, Wash.

This evaluation of the relative efficacy of therapies for localized prostate cancer is part of a multi-institutional study by the Prostate Patient Outcomes Research Team (Prostate PORT) at Dartmouth College Medical School and Harvard Medical School. "The paper has received so much attention because it raises some very controversial issues regarding present treatments for prostate cancer," declares Craig Fleming, a former assistant professor of medicine at Dartmouth and currently president of Health Outcomes Associates in Vancouver, Wash.

"Prostate cancer is one of the most common cancers among men in this country, and currently 35,000 men die each year with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide